The goal of this clinical trial is to learn if agenT-797 is safe to use on people undergoing allogenic hematological stem cell transplantation (SCT). The main …

Allogenic Stem Cell TransplantationMyeloid MalignanciesLymphoid Malignancies+3 more

~Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Wisconsin, MadisonNCT07758218

Phase 1

UW26119: Maintenance Treatment With Imetelstat in Patients With High-Risk Myeloid Neoplasms After Allogeneic Stem Cell Transplantation

The purpose of this clinical trial is to learn if imetelstat is safe to use in participants with high-risk myeloid malignancies who have received an allogenic …

High-risk Myeloid MalignancyAllogenic Stem Cell TransplantationAcute Myeloid Leukemia (AML)+6 more

~Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of Wisconsin, MadisonNCT07909733